LOW SHEAR-STRESS CAN INITIATE VON-WILLEBRAND FACTOR-DEPENDENT PLATELET-AGGREGATION IN PATIENTS WITH TYPE-IIB AND PLATELET-TYPE VON-WILLEBRAND DISEASE

被引:28
|
作者
MURATA, M
FUKUYAMA, M
SATOH, K
FUJIMURA, Y
YOSHIOKA, A
TAKAHASHI, H
HANDA, M
KAWAI, Y
WATANABE, K
IKEDA, Y
机构
[1] KEIO UNIV,SCH MED,DEPT INTERNAL MED,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN
[2] KEIO UNIV,SCH MED,DEPT LAB MED,TOKYO 160,JAPAN
[3] TORAY INDUSTRIES LTD,BASIC RES LABS,KANAGAWA 248,JAPAN
[4] WASEDA UNIV,DEPT CHEM ENGN,TOKYO 160,JAPAN
[5] NARA MED UNIV,DEPT BLOOD TRANSFUS,NARA 634,JAPAN
[6] NARA MED UNIV,DEPT PEDIAT,NARA 634,JAPAN
[7] NIIGATA UNIV,SCH MED,DEPT MED 1,NIIGATA 951,JAPAN
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 92卷 / 03期
关键词
SHEAR FORCE; PLATELETS; GLYCOPROTEIN LB-IX COMPLEX; THROMBOCYTOPENIA; BLEEDING DISORDERS;
D O I
10.1172/JCI116735
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Platelets exposed to shear stress aggregate in the absence of exogenously added agonists, utilizing distinct platelet membrane receptors and ligands depending upon the level of shear stress applied. Using a modified cone and plate type viscometer, we previously demonstrated that, under low shear stress (18 dyn/cm2), aggregation is mediated by platelet membrane glycoprotein (GP) IIb-IIIa and fibrinogen, whereas aggregation induced by high shear stress (108 dyn/cm2) requires the binding of von Willebrand factor (vWF) to both GPIb-IX and GPIIb-IIIa (Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, 1. Itagaki, et al. 1991. J. Clin. Invest. 87:1234-1240). Here we report that vWF-dependent aggregation occurs under low shear stress in citrated platelet-rich plasma (PRP) from two types of congenital bleeding disorders, platelet-type von Willebrand disease (vWD) and type IIB vWD, in both of which ristocetin-induced aggregation is known to be heightened. Aggregation induced by low shear stress was enhanced in both types of disorders compared to normal controls, and the enhancement was completely abolished by anti-vWF monoclonal antibody NMC-4, which blocks the GPIb-binding site on vWF. Under high shear stress, the extent of maximal aggregation was not different between controls and the patient groups although maximal aggregation was reached much more quickly in the latter. When citrated PRP was exposed to a gradient of shear stress (6 to 108 dyn/cm2 over a 5-min period), vWF-dependent aggregation, as judged from the inhibitory effect of NMC4, first occurred at 14 dyn/cm2 in platelet-type vWD and at 10-12 dyn/cm2 in type IIB vWD, as compared with more than 81+/-20.1 dyn/cm2 in control platelets. These results suggest that an abnormality in either vWF or GPIb-IX triggers the aggregation-inducing interaction of the two molecules under low shear stress, which might explain the intravascular platelet clumping, that presumably underlies the thrombocytopenia observed in these bleeding disorders.
引用
收藏
页码:1555 / 1558
页数:4
相关论文
共 50 条
  • [1] LOW SHEAR-STRESS INITIATES VON-WILLEBRAND FACTOR-DEPENDENT PLATELET-AGGREGATION IN PATIENTS WITH PLATELET-TYPE AND TYPE-IIB VON-WILLEBRAND DISEASE
    FUKUYAMA, M
    SATOH, K
    FUJIMURA, Y
    YOSHIOKA, A
    TAKAHASHI, H
    MORIKI, T
    MURATA, M
    HANDA, M
    IKEDA, Y
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 964 - 964
  • [2] SHEAR STRESS-INDUCED PLATELET-AGGREGATION IN VARIOUS TYPES OF VON-WILLEBRAND DISEASE
    NAKAGAWANISHIMURA, Y
    SUGIMOTO, M
    TSUJI, S
    KUWAHARA, M
    NISHIO, K
    TAKAHASHI, Y
    FUJIMURA, Y
    MURATA, M
    HANDA, M
    IKEDA, Y
    YOSHIOKA, A
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1995, 61 (04) : 189 - 196
  • [3] TOKARACETIN, A NEW PLATELET ANTAGONIST THAT BINDS TO PLATELET GLYCOPROTEIN IB AND INHIBITS VON-WILLEBRAND FACTOR-DEPENDENT SHEAR-INDUCED PLATELET-AGGREGATION
    KAWASAKI, T
    TANIUCHI, Y
    HISAMICHI, N
    FUJIMURA, Y
    SUZUKI, M
    TITANI, K
    SAKAI, Y
    KAKU, S
    SATOH, N
    TAKENAKA, T
    HANDA, M
    SAWAI, Y
    [J]. BIOCHEMICAL JOURNAL, 1995, 308 : 947 - 953
  • [4] SHEAR-INDUCED PLATELET-AGGREGATION (SIPA) IS ALTERED IN PATIENTS WITH VON-WILLEBRAND DISEASE (VWD)
    PARETI, FI
    DINICOLO, P
    BRESSI, C
    ZIGHETTI, L
    MANNUCCI, PM
    RUGGERI, ZM
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1182 - 1182
  • [5] LEU-697 -] VAL MUTATION IN MATURE VON-WILLEBRAND-FACTOR IS RESPONSIBLE FOR TYPE-IIB VON-WILLEBRAND DISEASE
    HILBERT, L
    GAUCHER, C
    DEROMEUF, C
    HORELLOU, MH
    VINK, T
    MAZURIER, C
    [J]. BLOOD, 1994, 83 (06) : 1542 - 1550
  • [6] Platelet-type von Willebrand disease
    Miller, JL
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 75 (06) : 865 - 869
  • [7] EFFECT OF TYPE-IIB VON-WILLEBRAND DISEASE MUTATION ARG-(545) CYS ON PLATELET GLYCOPROTEIN-IB BINDING - STUDIES WITH RECOMBINANT VON-WILLEBRAND-FACTOR
    INBAL, A
    KORNBROT, N
    HARRISON, P
    RANDI, AM
    SADLER, JE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1008 - 1008
  • [8] PLATELET-TYPE VON WILLEBRAND DISEASE PLATELET AGGREGATING FACTOR - A NOVEL FUNCTIONAL ASSAY OF VON WILLEBRAND FACTOR
    TAKAHASHI, H
    TATEWAKI, W
    HANANO, M
    SHIBATA, A
    [J]. THROMBOSIS RESEARCH, 1987, 48 (04) : 475 - 485
  • [9] ARG578GLN MUTATIONS IN THE VON-WILLEBRAND-FACTOR GENE IN 3 UNRELATED CASES OF TYPE-IIB VON-WILLEBRAND DISEASE
    PIAO, YC
    LAVERGNE, JM
    BOYERNEUMANN, C
    SCHANDELONG, A
    ALESSI, MC
    MEYER, D
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 787 - 789
  • [10] NEW MUTATION ILE(546)-]VAL IN A FAMILY WITH TYPE-IIB VON-WILLEBRAND DISEASE CHARACTERIZED BY SPONTANEOUS PLATELET-AGGREGATION, THROMBOCYTOPENIA AND NORMAL LEVELS OF RISTOCETIN COFACTOR
    FEDERICI, AB
    STABILE, F
    CANCIANI, MT
    MIYATA, S
    WARE, JL
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1170 - 1170